Search Results for "NCI" | Oncology Voice Network

Tom Caravela

Where Did My Interview Go Wrong?

Apr 24^th • 1 min read

Tom Caravela

Interview Differentiator-Be a Story Teller

Mar 22^nd • 1 min read

Tom Caravela

Job Search Checklist for Aspiring Medical Science Liaisons

May 17^th • 2 mins read

Tom Caravela

MSL Retention – What Matters Most

Mar 15^th • 2 mins read

Tom Caravela

7 High-Cost Interview Mistakes that are Easy to Avoid

Jul 28^th • 1 min read

Tom Caravela

MSL Evolution: New Trends and Titles That May Emerge

Apr 5^th • 1 min read

Tom Caravela

MSL People Skills: Top 10 Tips for Better Engagement

Apr 20^th • 8 mins read

Bridget Rasmusson

Positioning Yourself to Become an MSL in 2022

Dec 21^st • 10 mins read

iNIZIO

Transforming oncology: Five frontiers driving progress in cancer care

May 16^th • 5 mins read

iNIZIO

Expert perspectives live from ASCO® 2025

Jul 2^nd • 1 min read

Charles Oo, Barbara Ameer

Revamping the ever-changing landscape of drug development processes in the midst of COVID-19 pandemic

Apr 29^th • 2 mins read

B. Gyawali, E. G. E. de Vries, U. Dafni, T. Amaral, J. Barriuso, J. Bogaerts, A. Calles, G. Curigliano, C. Gomez-Roca, B. Kiesewetter, S. Oosting, A. Passaro, G. Pentheroudakis, M. Piccart, F. Roitberg, J. Tabernero, N. Tarazona, D. Trapani, R. Wester, G.

Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring

Apr 20^th • 8 mins read

A. Haslam, M.S. Kim, V. Prasad

Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020

Apr 20^th • 7 mins read

Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin

Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years

Apr 7^th • 12 mins read

Pai, Rekha

Advances in basic research in oncology in 2020: Bridging basic science and clinical care

Mar 24^th • 1 min read

Ali Raza Khaki

Loose Regulatory Standards Portend a New Era of Imprecision Oncology

Dec 1^st • 4 mins read

Carrie Printz

First person profile: William Sellers, MD

Nov 6^th • 2 mins read

Ioannis Tsagakis and Maria Papatriantafyllou

Safeguarding cancer research funding by European charities amidst the COVID-19 pandemic

Nov 22^nd • 3 mins read

Xuanyi Li, Elizabeth A. Sigworth, Adrianne H. Wu, Jess Behrens, Shervin A. Etemad, Seema Nagpal, Ronald S. Go, Kristin Wuichet, Eddy J. Chen, Samuel M. Rubinstein, Neeta K. Venepalli, Benjamin F. Tillman, Andrew J. Cowan, Martin W. Schoen, Andrew Malty, J

Seven decades of chemotherapy clinical trials: a pan-cancer social network analysis

Oct 16^th • 12 mins read

Siddharth Agrawal, Nidhi Bansal

Advances and Challenges in Pediatric and Childhood Cancers

Jun 27^th • 2 mins read

Navigation

Results for 'NCI'

Where Did My Interview Go Wrong?

Interview Differentiator-Be a Story Teller

Job Search Checklist for Aspiring Medical Science Liaisons

MSL Retention – What Matters Most

7 High-Cost Interview Mistakes that are Easy to Avoid

MSL Evolution: New Trends and Titles That May Emerge

MSL People Skills: Top 10 Tips for Better Engagement

Positioning Yourself to Become an MSL in 2022

Transforming oncology: Five frontiers driving progress in cancer care

Expert perspectives live from ASCO® 2025

Revamping the ever-changing landscape of drug development processes in the midst of COVID-19 pandemic

Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring

Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020

Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years

Advances in basic research in oncology in 2020: Bridging basic science and clinical care

Loose Regulatory Standards Portend a New Era of Imprecision Oncology

First person profile: William Sellers, MD

Safeguarding cancer research funding by European charities amidst the COVID-19 pandemic

Seven decades of chemotherapy clinical trials: a pan-cancer social network analysis

Advances and Challenges in Pediatric and Childhood Cancers

Related Topics